BPC-157 vs FGL (Fibroblast Growth-Like)
Overview
BPC-157 and FGL (Fibroblast Growth-Like) are both healing & recovery peptides, but they differ in mechanism, dosing, and regulatory status.
This page compares BPC-157 and FGL (Fibroblast Growth-Like) across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| BPC-157 | FGL (Fibroblast Growth-Like) | |
|---|---|---|
| Category | Healing & Recovery | Healing & Recovery |
| Regulatory status (US) | Compounding (Rx) — Apr 2026 | Research use only |
| Typical dosage | 250-500 mcg | 1 mg |
| Frequency | daily | daily |
| Reported benefits | Accelerated wound healing, tendon and ligament repair, gut health improvement, reduced inflammation, neuroprotective effects | Neuroprotection, neural repair, cognitive support |
| Reported side effects | Generally well-tolerated. Rare: injection site reactions, mild fatigue | Research phase, limited data |
Key differences
Primary use. BPC-157 is categorised under Healing & Recovery, while FGL (Fibroblast Growth-Like) falls under Healing & Recovery. Because they target a similar goal, they are common alternatives to weigh against each other.
Regulatory status. BPC-157: not FDA-approved; compounding permitted with a prescription as of April 2026. FGL (Fibroblast Growth-Like): not FDA-approved; treated as a research compound.
Dosing. BPC-157 is typically dosed at 250-500 mcg (daily). FGL (Fibroblast Growth-Like) is typically dosed at 1 mg (daily).
Can you stack them?
Some protocols combine peptides, but stacking BPC-157 and FGL (Fibroblast Growth-Like) has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between BPC-157 and FGL (Fibroblast Growth-Like)?
- BPC-157 and FGL (Fibroblast Growth-Like) are both healing & recovery peptides, but they differ in mechanism, dosing, and regulatory status. BPC-157 is not FDA-approved; compounding permitted with a prescription (as of April 2026), whereas FGL (Fibroblast Growth-Like) is not FDA-approved; generally classified as a research compound.
- What is BPC-157 used for?
- Healing & recovery, gut health.
- What is FGL (Fibroblast Growth-Like) used for?
- Neural repair peptide.
- Can you take BPC-157 and FGL (Fibroblast Growth-Like) together?
- Some users combine peptides within a single protocol, but stacking BPC-157 and FGL (Fibroblast Growth-Like) has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is BPC-157 or FGL (Fibroblast Growth-Like) FDA-approved?
- BPC-157 is not FDA-approved; compounding permitted with a prescription (as of April 2026). FGL (Fibroblast Growth-Like) is not FDA-approved; generally classified as a research compound.
Read the full articles
- BPC-157 — full monograph: mechanism, research, dosing & references
- FGL (Fibroblast Growth-Like) — full monograph: mechanism, research, dosing & references